These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 14503544)

  • 21. Fluconazole versus itraconazole for antifungal prophylaxis in neutropenic patients with haematological malignancies: a meta-analysis of randomised-controlled trials.
    Vardakas KZ; Michalopoulos A; Falagas ME
    Br J Haematol; 2005 Oct; 131(1):22-8. PubMed ID: 16173959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generic substitution of itraconazole resulting in sub-therapeutic levels and resistance.
    Pasqualotto AC; Denning DW
    Int J Antimicrob Agents; 2007 Jul; 30(1):93-4. PubMed ID: 17412566
    [No Abstract]   [Full Text] [Related]  

  • 23. Prevention of Infectious Complications in Patients With Chronic Granulomatous Disease.
    Slack MA; Thomsen IP
    J Pediatric Infect Dis Soc; 2018 May; 7(suppl_1):S25-S30. PubMed ID: 29746681
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic bullous disease of childhood and a paecilomyces lung infection in chronic granulomatous disease.
    Sillevis Smitt JH; Leusen JH; Stas HG; Teeuw AH; Weening RS
    Arch Dis Child; 1997 Aug; 77(2):150-2. PubMed ID: 9301356
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence-based review of antifungal prophylaxis in neutropenic patients with haematological malignancies.
    Glasmacher A; Prentice AG
    J Antimicrob Chemother; 2005 Sep; 56 Suppl 1():i23-i32. PubMed ID: 16120631
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravenous and oral sequential itraconazole antifungal prophylaxis in paediatric stem cell transplantation recipients: a pilot study for evaluation of safety and efficacy.
    Grigull L; Kuehlke O; Beilken A; Sander A; Linderkamp C; Schmid H; Seidemann K; Sykora KW; Schuster FR; Welte K
    Pediatr Transplant; 2007 May; 11(3):261-6. PubMed ID: 17430480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Successful treatment of entomophthoromycosis with itraconazole.
    Kabra SK; Jain Y; Sudhin T; Iyer KV; Ninan SA; Seth V
    Indian Pediatr; 1998 Feb; 35(2):163-6. PubMed ID: 9707860
    [No Abstract]   [Full Text] [Related]  

  • 28. Itraconazole prophylaxis in lung transplant recipients receiving tacrolimus (FK 506): efficacy and drug interaction.
    Shitrit D; Ollech JE; Ollech A; Bakal I; Saute M; Sahar G; Kramer MR
    J Heart Lung Transplant; 2005 Dec; 24(12):2148-52. PubMed ID: 16364864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rare diagnosis in a neonate who presents with fever.
    Davoodi P; Wright SA; Brown EV; Perry JR
    Clin Pediatr (Phila); 2015 Jan; 54(1):91-3. PubMed ID: 25022948
    [No Abstract]   [Full Text] [Related]  

  • 30. Antifungal prophylaxis among allogeneic hematopoietic stem cell transplant recipients: current issues and new agents.
    Strasfeld L; Weinstock DM
    Expert Rev Anti Infect Ther; 2006 Jun; 4(3):457-68. PubMed ID: 16771622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Itraconazole: an update on pharmacology and clinical use for treatment of invasive and allergic fungal infections.
    Lestner J; Hope WW
    Expert Opin Drug Metab Toxicol; 2013 Jul; 9(7):911-26. PubMed ID: 23641752
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Misleading statements in industry-sponsored meta-analysis of itraconazole.
    Gøtzsche PC; Johansen HK
    J Clin Oncol; 2005 Dec; 23(36):9428-9; author reply 9429-32. PubMed ID: 16361645
    [No Abstract]   [Full Text] [Related]  

  • 33. How to improve the design of trials of antifungal prophylaxis among neutropenic adults with acute leukemia.
    Menichetti F
    Clin Infect Dis; 2004 Oct; 39 Suppl 4():S181-4. PubMed ID: 15546115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Diagnosis and treatment of aspergillosis in the patients with chronic granulomatous disease].
    Kurenko-Deptuch M; Wolska-Kuśnierz B; Heropolitańska-Pliszka E; Klaudel-Dreszler M; Pac M; Pietrucha B; Garczewska B; Bernatowska E
    Przegl Epidemiol; 2006; 60(1):43-7. PubMed ID: 16758737
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cutaneous alternariosis with chronic granulomatous disease.
    Uenotsuchi T; Moroi Y; Urabe K; Fukagawa S; Tsuji G; Matsuda T; Furue M
    Eur J Dermatol; 2005; 15(5):406-8. PubMed ID: 16172055
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical manifestation and treatment of blood disease combined with invasive fungal infection].
    Shen ZX; Chen QS
    Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(21):1447-8. PubMed ID: 16061018
    [No Abstract]   [Full Text] [Related]  

  • 37. Candida lusitaniae and chronic granulomatous disease.
    Estrada B; Mancao MY; Polski JM; Figarola MS
    Pediatr Infect Dis J; 2006 Aug; 25(8):758-9. PubMed ID: 16874186
    [No Abstract]   [Full Text] [Related]  

  • 38. [The future of antifungal agents].
    Maesaki S
    Rinsho Ketsueki; 2007 Jan; 48(1):26-35. PubMed ID: 17313074
    [No Abstract]   [Full Text] [Related]  

  • 39. The place for itraconazole in treatment.
    Maertens J; Boogaerts M
    J Antimicrob Chemother; 2005 Sep; 56 Suppl 1():i33-i38. PubMed ID: 16120632
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Efficacy of intravenous administration of itraconazole on fungal infections in immunocompromised patients with hematological diseases].
    Wang JZ; Huang XJ; Liu KY; Liu DH; Chen H; Xu LP; Lu J; Zhang YC; Han W; Lu DP
    Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(21):1481-3. PubMed ID: 16061027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.